Prayson Tumors Flashcards
Low grade astrocytoma
WHO II. 90% derived from fibrillary astrocytes. Frontral lobe> parietal > temporal > occipital. Most common in 4th decade (30s). 5-10 year survival after surgery
Anaplastic astrocytoma
WHO III. Fourth and fith decades (30-40s),
Small cell GBM
WHO IV. EGFR amplificiation
Glioblastoma
WHO IV. Most common glioma, 5th and 6th decade (40-50s), M>F. Risks: hydrocarbon exposure and radiation. Giant cell variant may have slightly better prognosis. Survival without therapy 14-16 weeks, w/ therapy 1 year. Metasis rare (#1 lung, #2 bone)
Gliosarcoma
WHO IV. Temporal lobe is most common site, increased mets (sarcoma part). Sarcoma may be fibrosarcoma, fibrous histiocytoma, rarely chondrosarc, rhabdo, or angio.
Pilocytic astrocytoma
WHO I. Most common glioma in children, assoc w/ NF1 (especially brainstem and optic nerve). Cystic mass with enhancing mural nodule. 5yr survival 85%. Infiltration of meninges does not affect prognosis
Subependymal giant cell astrocytoma
WHO I. Increased intracranial pressure 2/2 obstruction of foramen of Monro. Assoc w/ tuberous sclerosis, usually <20 years. Elevated nodule involving lateral or 3rd ventricle. Good prognosis, low recurrence rate
Pleomorphic xanthoastocytoma
WHO II. Most common in first 2 decades (<20), siezures. Assoc w/ cortical malformations. Temporal and parietal lobes, cystic w/ mural nodule, superficial nodule in contact w/ leptomeninges. Well circumscribed. Perivascular lymphs, lipidized astrocytes, reticulin rich,
Anaplastic: increased mitosis and necrosis.
Malignant transformation or recurrence in 15-20%
Optic nerve glioma
First decade, NF1 assoc- bilateral. adults-ant. optic pathway aggressive. Growth within optic sheath-
Astroblastoma
Children and young adults, cerebral hemispheres, discrete circumscribed mass. Perivascular rosettes formed by elongated cells.
Desmoplastic Infantile astrocytoma/ganglioglioma
WHO I. Superficial frequently dural based. Most <1 year of age, M>F. Desmoplasia with spindled astrocytes, derived from subpial astrocytes. Cellular foci of small blue cell with high proliferation do not alter prognosis. Increased head circumfrence with bulging fontanelles. Cystic, GFAP +
Chrodiod glioma
WHO II. Anterior 3rd ventricle, F>M. Obstructive hydrocephalus. Solid (soft and mucoid tumor) composed of clusters or cord of epitheliod cells with variably mucinous stroma, stromal lymphoplasmacytic infiltrate and numeorus russell bodies. GFAP+ Rare, slow growing, recur if incompletely excised
Ganglioglioma
WHO I. Glioneuronal tumor. Most common in temporal lobe and children > adults. Most pt.s present w/chronic epilepsy. Cystic tumor w/ calcified mural nodule. Atypical neurons, calcifications are common, granular bodies, perivascular lymphs, Assoc w/ cortical malformations. Rare anaplastic WHO grade III, w/ increased mitosis and necrosis
Gangliocytoma
WHO I. Composed of mature ganglion cells
Dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos)
Cowden’s synd (PTEN germline mutation). Hamartomatous lesion of ganglion cells
Glioneuronal tumors
Ganglioglioma, papillary glioneuronal tumor, rosette-forming glioneuronal turmor of the 4th ventricle (all WHO I)
Angiocentric glioma
WHO I. Children/young adults, epilepsy assoc. Angiocentric growth of monomorphos biopolar cells and features of ependymal differentation. rare slow growning
Oligodendroglioma
WHO II. Mean age 35-45, white matter origin, frontal lobe most common site. chicken wire vasculature, calcifications prominent at the periphery, may have meningeal invasion, minigemistocytes-degenerative change.
GFAP - or focally + (minigemistocytes +), S100, Leu-7+
1p/19q codeletion/ IDH mutant, TERT mutant
Survival 10-15 years
Anaplastic- WHO III, >5 mits/10 HPF
Dysembryoplastic neuroepithelial tumor (DNET)
WHO I. Young pts w/ hx of chronic epilepsy. Multinodular, multicystic, cortical based. Assoc w/ cortical dysplasia. Microcystic, floating neurons
Central neurocytoma
WHO II. 20-40 years, Intraventricular near septum pellucidum or in 3rd ventricle (rare extraventricular). descrete, often partly calcified, uniform nuclie with speckled chromatin, fibrillary background, mitosis rare.
GFAP -, synapto, NSE, and B-tubulin +
EM: Dense core granules, neurotubules, and neurofilaments
Flexner-Winersteiner Rosettes
Small lumen, cuboidal lining. True Rosette
Retinoblastoma
Ependymal Rosettes
Ependymal lining, ciliary attachment (blephroplasts), canal/chanel with long lumen. True rosette
Homer Wright
Fibrillary core, neuroblastic differentation. Psuedorosette
Medulloblastoma, neuroblastoma
Ependymoma
WHO II. More common in children, Most common tumor of the spinal cord, ventricle (especially 4th). 71% are infratentorial. Well demarcated, soft, lobular mass. Perivascular pseudorosettes and true ependymal rosettes, marked fibrillarity. Can have calcs/ossificatin / cartilage. Obstruction of CSF is presenting symptom.
Variants (no clinical significance): Cellular, papillary, clear cell, tanycytic, melanotic, lipomatous, giant cell, signet ring
GFAP, S100, EMA (dots and rings)+ CD99 highlights surface membranes in intracytoplasmic lumina.
NF2 mutations common in spinal tumors, Ch 22q loss and 1q gains are common
Extent of resection (best predictor) and location and are most prognostic, better prognosis in adults and spinal and supratentorial tumors.
Anapastic- WHO III, Increased mits, necrosis, etc
Subependymoma
WHO I. Adults M>F, asymptomatic, septum pellucidum, floor, lateral recess of 4th ventricle, no rosettes or pseudorosettes, microcystic change
GFAP and S100+,
Myxopapillary ependymoma
WHO I. M>F, 30-40 years, may be locally infiltrative, hemorrhagic or lobular. 25% encapsulated. Filum terminale > subcu sacrococcygeal region or other spinal cord location. Intracellular mucin, mucoid stroma.
GFAP, mucicarmine, and alcian blue +